Women's Health

Evofem makes top-to-bottom cuts to save cash, slashing CEO pay by 40% and eliminating positions
Evofem makes top-to-bottom cuts to save cash, slashing CEO pay by 40% and eliminating positions
Fierce Biotech
Evofem Biosciences
layoffs
contraceptives
Women's Health
Flag link:
Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'
Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'
Fierce Biotech
Organon
Women's Health
endometriosis
Flag link:
Materna Medical raises $22M to heal women’s pelvic floors
Materna Medical raises $22M to heal women’s pelvic floors
MedCity News
Medtech
devices
Materna Medical
funding
Women's Health
Flag link:
Drugmaker seeks FDA approval of over-the-counter birth control pill
Drugmaker seeks FDA approval of over-the-counter birth control pill
Stat
HRA Pharma
contraceptives
oral contraceptives
FDA
Women's Health
Flag link:
Leaders Weigh in on how the Fall of Roe Will Affect Biopharma
Leaders Weigh in on how the Fall of Roe Will Affect Biopharma
BioSpace
Supreme Court
Women's Health
abortion
abortion pill
Flag link:
A new spinout wades into ovarian aging, armed with a seed round and experimental drugs from Mass General
A new spinout wades into ovarian aging, armed with a seed round and experimental drugs from Mass General
Endpoints
Oviva Therapeutics
Women's Health
ovarian aging
funding
Flag link:
CooperSurgical to acquire Reproductive Health division of Cook Medical for $875M
CooperSurgical to acquire Reproductive Health division of Cook Medical for $875M
MedCity News
CooperSurgical
Cook Medical
M&A
Women's Health
devices
Flag link:
Organon gives staff the day off for International Women's Day to focus on their health
Organon gives staff the day off for International Women's Day to focus on their health
Fierce Pharma
Organon
Merck
Women's Health
employee satisfaction
employees
Flag link:
Amyris to buy women’s wellness firm MenoLabs
Amyris to buy women’s wellness firm MenoLabs
Pharmaceutical Business Review
Amyris
MenoLabs
menopause
M&A
Women's Health
Flag link:
Merck, putting $150M on the table, doubles down on pledge tackle maternal mortality and health inequities
Merck, putting $150M on the table, doubles down on pledge tackle maternal mortality and health inequities
Fierce Pharma
Merck
maternal health
Women's Health
Flag link:
Organon makes another women’s health move with deal for endometriosis-focused Forendo
Organon makes another women’s health move with deal for endometriosis-focused Forendo
MedCity News
Organon
Forendo Pharma
Merck
endometriosis
M&A
Women's Health
Flag link:
Meet 8 Female Founders Disrupting The $600 Billion Menopause Market
Meet 8 Female Founders Disrupting The $600 Billion Menopause Market
Forbes
Women's Health
menopause
Flag link:
Merck women's health spinoff Organon debuts first awareness campaign, taking on unplanned pregnancy
Merck women's health spinoff Organon debuts first awareness campaign, taking on unplanned pregnancy
Fierce Pharma
Organon
Merck
spinoffs
Women's Health
Flag link:
Organon Makes Women’s Health a Priority
Organon Makes Women’s Health a Priority
Pharmaforum
Organon
Merck
Women's Health
Flag link:
Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs
Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs
Fierce Pharma
Merck
Organon
Women's Health
spinoffs
Flag link:
Independent from Merck, Organon CEO lays out newco's women's health ambitions, M&A plans
Independent from Merck, Organon CEO lays out newco's women's health ambitions, M&A plans
Fierce Pharma
Organon
Merck
spinoffs
NYSE
Women's Health
Flag link:
Merck spinoff Organon to begin trading in June
Merck spinoff Organon to begin trading in June
Seeking Alpha
Merck
Organon
spinoff
Women's Health
biosimilars
Flag link:
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
AbbVie
Women's Health
Allergan
Humira
M&A
Flag link:
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Fierce Biotech
Bayer
KaNDy Therapeutics
M&A
Women's Health
menopause
hot flashes
NT-814
Flag link:
Olema Oncology grabs $54M for breast cancer program
Olema Oncology grabs $54M for breast cancer program
Fierce Biotech
Olema Oncology
Women's Health
breast cancer
OP-1250
Flag link:

Pages